Torii Pharmaceutical Co (TSE:4551) Total Stockholders Equity : 円119,040 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Torii Pharmaceutical Co Total Stockholders Equity?

Torii Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was 円119,040 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Torii Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was 円4,235.52. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Torii Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Torii Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Torii Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torii Pharmaceutical Co Total Stockholders Equity Chart

Torii Pharmaceutical Co Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

113,125.00

115,089.00

117,014.00

119,224.00

120,132.00

Torii Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															117,067.00	118,665.00	118,594.00	120,132.00	119,040.00

Torii Pharmaceutical Co (TSE:4551) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Torii Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(119040	-	0)	/	28.1052
	=	4,235.52

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Torii Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	119040
	=	0.00

Torii Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Torii Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Torii Pharmaceutical Co (TSE:4551) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torii Pharmaceutical Co Ltd (TSE:4551) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho, 3-chome, Chuo-ku, Tokyo, JPN, 103-8439

Website

http://www.torii.co.jp

Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Torii Pharmaceutical Co (TSE:4551) Headlines

No Headlines